2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC2692
  



  

  
Submitter : 
  

  
Mrs. Kristine Witt
  

  
Date & Time: 
  

  
12/06/2006 09:12:22
  



  

  
Organization : 
  

  
Mrs. Kristine Witt
  



  

  
Category : 
  

  
Individual Consumer
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
 I would ask that the FDA favor all viable alternatives to fetal tissue for vaccine manufacturing and not approve any protocols for vaccine production that rely on fetal tissue use.